Literature DB >> 26789102

Long-term side effects of glucocorticoids.

Merih Oray1,2,3, Khawla Abu Samra1,2, Nazanin Ebrahimiadib1,2, Halea Meese1,2, C Stephen Foster1,2,4.   

Abstract

INTRODUCTION: Glucocorticoids represent the standard therapy for reducing inflammation and immune activation in various diseases. However, as with any potent medication, they are not without side effects. Glucocorticoid-associated side effects may involve most major organ systems. Musculoskeletal, gastrointestinal, cardiovascular, endocrine, neuropsychiatric, dermatologic, ocular, and immunologic side effects are all possible. AREAS COVERED: This article analyzes English-language literature and provides an update on the most recent literature regarding side effects of systemic glucocorticoid treatment. EXPERT OPINION: The risk/benefit ratio of glucocorticoid therapy can be improved by proper use. Careful monitoring and using appropriate preventive strategies can potentially minimize side effects.

Entities:  

Keywords:  corticosteroids; glucocorticoids; immunosuppression; side effects

Mesh:

Substances:

Year:  2016        PMID: 26789102     DOI: 10.1517/14740338.2016.1140743

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  116 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

2.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

Review 3.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 4.  Corticosteroids for pneumonia.

Authors:  Anat Stern; Keren Skalsky; Tomer Avni; Elena Carrara; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2017-12-13

5.  Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.

Authors:  Haruhiko Shiiya; Jun Nakajima; Hiroshi Date; Toyofumi Fengshi Chen-Yoshikawa; Kiminobu Tanizawa; Tomohiro Handa; Takahiro Oto; Shinji Otani; Toshio Shiotani; Yoshinori Okada; Yasushi Matsuda; Takeshi Shiraishi; Toshihiko Moroga; Masato Minami; Soichiro Funaki; Masayuki Chida; Ichiro Yoshino; Go Hatachi; Yukari Uemura; Masaaki Sato
Journal:  Surg Today       Date:  2021-02-12       Impact factor: 2.549

6.  Assessment of side effects after serial intralesional steroid injections for idiopathic subglottic stenosis.

Authors:  Ozlem Onerci Celebi; Sungjin A Song; Alena Santeerapharp; Kanittha Choksawad; Ramon A Franco
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-18       Impact factor: 2.503

7.  Current clinical management of patients with glioblastoma.

Authors:  Stephen Lowe; Krishna P Bhat; Adriana Olar
Journal:  Cancer Rep (Hoboken)       Date:  2019-09-04

8.  Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation.

Authors:  Sylvia J Gasparini; Michael M Swarbrick; Sarah Kim; Lee J Thai; Holger Henneicke; Lauryn L Cavanagh; Jinwen Tu; Marie-Christin Weber; Hong Zhou; Markus J Seibel
Journal:  Diabetologia       Date:  2019-05-16       Impact factor: 10.122

Review 9.  Glycemic Management in the Operating Room: Screening, Monitoring, Oral Hypoglycemics, and Insulin Therapy.

Authors:  Elizabeth Duggan; York Chen
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

10.  Glucocorticoid use and complications following immune checkpoint inhibitor use in melanoma.

Authors:  Kapil Agarwal; Nadia Yousaf; Daniel Morganstein
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.